Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）

Clinical trial NCT06417281 · COMPLETED

Trial details

NCT number: NCT06417281
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

5-aminolevulinic Acid Malignant Glioma of Brain

Start date: 2024-06-19
Primary completion: 2025-08-19
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.